+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-Vascular Stents - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140239
The global market for Non-Vascular Stents was estimated at US$1.5 Billion in 2023 and is projected to reach US$2.2 Billion by 2030, growing at a CAGR of 5.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Are Non-Vascular Stents and Why Are They Crucial for Patient Care?

Non-vascular stents are medical devices used to support and keep open passageways in non-vascular systems, such as the digestive, urinary, and respiratory tracts. These stents are primarily used to treat obstructions caused by tumors, strictures, or other blockages in organs such as the esophagus, bile ducts, ureters, and airways. Unlike vascular stents, which are used in arteries and veins, non-vascular stents focus on relieving obstructions in soft tissue organs, ensuring normal bodily functions like breathing, urination, or digestion are maintained. Materials used for non-vascular stents range from metal alloys to biodegradable polymers, allowing for tailored solutions based on the patient's specific condition. The use of non-vascular stents has become increasingly important in palliative care for patients with cancers that lead to blockages in these systems.

How Are Technological Advancements Revolutionizing the Non-Vascular Stents Market?

The non-vascular stents market has seen significant innovation in recent years, particularly with the development of advanced materials and stent designs. Biodegradable stents, which dissolve after a certain period, are gaining traction as they reduce the need for repeat procedures to remove the stent. Additionally, drug-eluting stents, which slowly release medication to prevent tissue inflammation or growth around the stent, are becoming more widely adopted. Improvements in stent flexibility and the development of self-expanding stents have enhanced the ease of implantation and reduced procedural risks. These technological advancements allow for more precise and less invasive treatment of blockages, improving patient outcomes and recovery times. As minimally invasive procedures gain popularity, non-vascular stents are increasingly being deployed as a solution for a range of conditions, particularly in patients who are not ideal candidates for more invasive surgeries.

How Are Demographic and Healthcare Trends Impacting the Non-Vascular Stents Market?

The rising incidence of diseases such as cancer, gastrointestinal disorders, and chronic obstructive pulmonary disease (COPD) is one of the primary drivers of demand for non-vascular stents. With aging populations across the globe, there is an increasing prevalence of conditions that lead to obstructions in the biliary, urinary, and respiratory tracts. This demographic shift is creating sustained demand for stenting procedures as part of both palliative and curative care. Moreover, advancements in healthcare infrastructure, particularly in emerging markets, have expanded access to medical devices such as non-vascular stents, increasing their adoption in regions previously underserved by medical technology. Additionally, the growing emphasis on patient comfort and quality of life, particularly in oncology, has led to a greater reliance on non-vascular stents as a solution to alleviate symptoms caused by obstructions.

What Factors Are Driving Growth in the Non-Vascular Stents Market?

The growth in the non-vascular stents market is driven by several factors. Technological advancements, such as the development of self-expanding and drug-eluting stents, are enhancing treatment outcomes and reducing complications, which in turn is driving wider adoption of these devices. The increasing prevalence of cancer and chronic diseases, particularly in aging populations, is also fueling demand for non-vascular stents as an essential part of palliative care. Furthermore, the shift toward minimally invasive procedures is driving the adoption of stents over more invasive surgical options, particularly for elderly patients or those with severe conditions. Expanding healthcare access in emerging markets, combined with growing investments in medical infrastructure, is opening up new opportunities for the non-vascular stents market. Finally, the trend toward personalized medicine, with customized stent designs for specific patient needs, is further bolstering market growth.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Urology Stents segment, which is expected to reach US$1.1 Billion by 2030 with a CAGR of a 5.1%. The Gastrointestinal Stents segment is also set to grow at 5.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was valued at $421.3 Million in 2023, and China, forecasted to grow at an impressive 4.9% CAGR to reach $347.3 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Non-Vascular Stents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Non-Vascular Stents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Non-Vascular Stents Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as BARD, A Becton, Dickinson Company, Boston Scientific Corporation, ConMed Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 11 Featured):

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, Inc.
  • ELLA-CS, s.r.o.
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Medtronic PLC
  • Synchron, Inc.
  • Taewoong Medical

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Non-Vascular Stents - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Gastrointestinal Disorders Drives Demand for Non-Vascular Stents in Endoscopic Procedures
  • Increasing Adoption of Urological Stents Expands Market for Non-Vascular Solutions in Kidney and Urinary Tract Treatments
  • Growing Use of Biliary Stents Fuels Market Growth in the Treatment of Bile Duct Obstructions and Gallstones
  • Technological Advancements in Self-Expanding Stents Propel Growth in Non-Vascular Applications for Digestive Health
  • Rising Demand for Non-Vascular Stents in Colorectal Cancer Treatment Expands Market for Minimally Invasive Oncology Solutions
  • Increasing Use of Pancreatic Stents Strengthens Market for Non-Vascular Stents in Gastrointestinal Surgeries
  • Emerging Focus on Non-Vascular Stents for Airway Management Fuels Growth in Respiratory and Pulmonary Applications
  • Rising Adoption of Non-Vascular Stents in Palliative Care Expands Opportunities for End-of-Life Interventions
  • Growing Demand for Non-Vascular Stents in Pediatric Patients Expands Market for Specialized Stenting Solutions
  • Technological Innovations in Biodegradable and Drug-Eluting Non-Vascular Stents Propel Growth in Long-Term Treatment Solutions
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Non-Vascular Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Non-Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Non-Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Non-Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Urology Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Gastrointestinal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 18: USA Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: USA 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
CANADA
  • Table 20: Canada Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: Canada Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: Canada 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
JAPAN
  • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 23: Japan Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 24: Japan Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: Japan 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
CHINA
  • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 26: China Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: China Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: China 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
EUROPE
  • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 29: Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Non-Vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: Europe 16-Year Perspective for Non-Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 32: Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: Europe 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
FRANCE
  • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 35: France Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: France Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: France 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
GERMANY
  • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 38: Germany Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Germany Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: Germany 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
ITALY
  • Table 41: Italy Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: Italy Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: Italy 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 44: UK Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: UK Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: UK 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 47: Rest of Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: Rest of Europe Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: Rest of Europe 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Asia-Pacific Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: Asia-Pacific 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 53: Rest of World Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 54: Rest of World Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: Rest of World 16-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, Inc.
  • ELLA-CS, s.r.o.
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Medtronic PLC
  • Synchron, Inc.
  • Taewoong Medical

Table Information